Changes in the epigenetic status of the SOX-9 promoter in human osteoarthritic cartilage

Journal of Bone and Mineral Research

Volumn 28, Issue 5, 2013, Pages 1050-1060

  Kim, Kyung Il ^a   Park, Youn Soo ^b   Im, Gun Il ^a  

^a Dongguk University Ilsan Hospital   (South Korea)

^b Samsung Medical Center   (South Korea)

Author keywords

DNA Methylation; Epigenetics; Histone Modification; Osteoarthritis; SOX 9

Indexed keywords

CCAAT BINDING FACTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; NUCLEAR FACTOR Y; TRANSCRIPTION FACTOR SOX9;

ACETYLATION; ADULT; AGED; ARTICLE; BINDING AFFINITY; CARTILAGE; CARTILAGE CELL; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; FEMALE; FEMUR NECK FRACTURE; GENE EXPRESSION; GENE SEQUENCE; HIP OSTEOARTHRITIS; HISTONE MODIFICATION; HUMAN; HUMAN CELL; MALE; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN EXPRESSION;

AZACITIDINE; BASE SEQUENCE; BLOTTING, WESTERN; DNA METHYLATION; DNA PRIMERS; EPIGENESIS, GENETIC; HUMANS; OSTEOARTHRITIS; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SOX9 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTORS;

EID: 84876738726     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.1843     Document Type: Article

References (45)

1. Lawrence RC, Helmick CG, Arnett FC, Deyo RA, Felson DT, Giannini EH, Heyse SP, Hirsch R, Hochberg MC, Hunder GG, Liang MH, Pillemer SR, Steen VD, Wolfe F., Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum. 1998; 41: 778-99.
2. Buckwalter JA, Mankin HJ, Grodzinsky AJ., Articular cartilage and osteoarthritis. Instr Course Lect. 2005; 54: 465-80.
3. Buckwalter JA, Mankin HJ., Articular cartilage: degeneration and osteoarthritis, repair, regeneration, and transplantation. Instr Course Lect. 1998; 47: 487-504.
4. Poschl E, Fidler A, Schmidt B, Kallipolitou A, Schmid E, Aigner T., DNA methylation is not likely to be responsible for aggrecan down regulation in aged or osteoarthritic cartilage. Ann Rheum Dis. 2005; 64: 477-80.
5. Goldring MB., The role of the chondrocyte in osteoarthritis. Arthritis Rheum. 2000; 43: 1916-26.
6. Goldring SR, Goldring MB., The role of cytokines in cartilage matrix degeneration in osteoarthritis. Clin Orthop Relat Res. 2004 Oct;(427 Suppl); S27-36.
7. Roach HI, Yamada N, Cheung KS, Tilley S, Clarke NM, Oreffo RO, Kokubun S, Bronner F., Association between the abnormal expression of matrix-degrading enzymes by human osteoarthritic chondrocytes and demethylation of specific CpG sites in the promoter regions. Arthritis Rheum. 2005; 52: 3110-24.
8. Roach HI, Aigner T., DNA methylation in osteoarthritic chondrocytes: a new molecular target. Osteoarthritis Cartilage. 2007; 15: 128-37.
9. Bernstein BE, Meissner A, Lander ES., The mammalian epigenome. Cell. 2007; 128: 669-81.
10. Robertson KD., DNA methylation and human disease. Nat Rev Genet. 2005; 6: 597-610.
11. Bird A., DNA methylation patterns and epigenetic memory. Genes Dev. 2002; 16: 6-21.
12. Attwood JT, Yung RL, Richardson BC., DNA methylation and the regulation of gene transcription. Cell Mol Life Sci. 2002; 59: 241-57.
13. Fuks F., DNA methylation and histone modifications: teaming up to silence genes. Curr Opin Genet Dev. 2005; 15: 490-5.
14. Bibikova M, Laurent LC, Ren B, Loring JF, Fan JB., Unraveling epigenetic regulation in embryonic stem cells. Cell Stem Cell. 2008; 2: 123-34.
15. Morgan HD, Santos F, Green K, Dean W, Reik W., Epigenetic reprogramming in mammals. Hum Mol Genet. 2005; 14 Spec No 1: R47-58.
16. Razin A, Cedar H., DNA methylation and genomic imprinting. Cell. 1994; 77: 473-6.
17. Razin A, Shemer R., DNA methylation in early development. Hum Mol Genet. 1995; 4: 1751-5.
18. Das PM, Singal R., DNA methylation and cancer. J Clin Oncol. 2004; 22: 4632-42.
19. Herranz M, Esteller M., DNA methylation and histone modifications in patients with cancer: potential prognostic and therapeutic targets. Methods Mol Biol. 2007; 361: 25-62.
20. Laird PW, Jaenisch R., DNA methylation and cancer. Hum Mol Genet. 1994; 3: 1487-95.
21. Cheung KS, Hashimoto K, Yamada N, Roach HI., Expression of ADAMTS-4 by chondrocytes in the surface zone of human osteoarthritic cartilage is regulated by epigenetic DNA de-methylation. Rheumatol Int. 2009; 29: 525-34.
22. da Silva MA, Yamada N, Clarke NM, Roach HI., Cellular and epigenetic features of a young healthy and a young osteoarthritic cartilage compared with aged control and OA cartilage. J Orthop Res. 2009; 27: 593-601.
23. Loeser RF, Im HJ, Richardson B, Lu Q, Chubinskaya S., Methylation of the OP-1 promoter: potential role in the age-related decline in OP-1 expression in cartilage. Osteoarthritis Cartilage. 2009; 17: 513-7.
24. Sesselmann S, Soder S, Voigt R, Haag J, Grogan SP, Aigner T., DNA methylation is not responsible for p21WAF1/CIP1 down-regulation in osteoarthritic chondrocytes. Osteoarthritis Cartilage. 2009; 17: 507-12.
25. Scott JL, Gabrielides C, Davidson RK, Swingler TE, Clark IM, Wallis GA, Boot-Handford RP, Kirkwood TB, Taylor RW, Young DA., Superoxide dismutase downregulation in osteoarthritis progression and end-stage disease. Ann Rheum Dis. 2010; 69: 1502-10.
26. Iliopoulos D, Malizos KN, Tsezou A., Epigenetic regulation of leptin affects MMP-13 expression in osteoarthritic chondrocytes: possible molecular target for osteoarthritis therapeutic intervention. Ann Rheum Dis. 2007; 66: 1616-21.
27. Kouzarides T., Chromatin modifications and their function. Cell. 2007; 128: 693-705.
28. Munshi A, Shafi G, Aliya N, Jyothy A., Histone modifications dictate specific biological readouts. J Genet Genomics. 2009; 36: 75-88.
29. Martin C, Zhang Y., The diverse functions of histone lysine methylation. Nat Rev Mol Cell Biol. 2005; 6: 838-49.
30. Volkel P, Angrand PO., The control of histone lysine methylation in epigenetic regulation. Biochimie. 2007; 89: 1-20.
31. Davis PK, Brackmann RK., Chromatin remodeling and cancer. Cancer Biol Ther. 2003; 2: 22-9.
32. Fullgrabe J, Kavanagh E, Joseph B., Histone onco-modifications. Oncogene. 2011; 30: 3391-403.
33. El Mansouri FE, Chabane N, Zayed N, Kapoor M, Benderdour M, Martel-Pelletier J, Pelletier JP, Duval N, Fahmi H., Contribution of H3K4 methylation by SET-1A to interleukin-1-induced cyclooxygenase 2 and inducible nitric oxide synthase expression in human osteoarthritis chondrocytes. Arthritis Rheum. 2011; 63: 168-79.
34. Lefebvre V, Huang W, Harley VR, Goodfellow PN, de Crombrugghe B., SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene. Mol Cell Biol. 1997; 17: 2336-46.
35. Lefebvre V, Behringer RR, de Crombrugghe B., L-Sox5, Sox6 and Sox9 control essential steps of the chondrocyte differentiation pathway. Osteoarthritis Cartilage. 2001; 9 Suppl A: S69-75.
36. Kulyk WM, Franklin JL, Hoffman LM., Sox9 expression during chondrogenesis in micromass cultures of embryonic limb mesenchyme. Exp Cell Res. 2000; 255: 327-32.
37. Mankin HJ, Dorfman H, Lippiello L, Zarins A., Biochemical and metabolic abnormalities in articular cartilage from osteoarthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J Bone Joint Surg. 1971; 53A: 523-37.
38. Lee JS, Im GI., SOX trio decrease in the articular cartilage with the advancement of osteoarthritis. Connect Tissue Res. 2011; 52: 496-502.
39. Wagner T, Wirth J, Meyer J, Zabel B, Held M, Zimmer J, Pasantes J, Bricarelli FD, Keutel J, Hustert E, Wolf U, Tommerup N, Schempp W, Scherer G., Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell. 1994; 79: 1111-20.
40. Dehne T, Karlsson C, Ringe J, Sittinger M, Lindahl A., Chondrogenic differentiation potential of osteoarthritic chondrocytes and their possible use in matrix-associated autologous chondrocyte transplantation. Arthritis Res Ther. 2009; 11: R133.
41. Yagi R, McBurney D, Laverty D, Weiner S, Horton WE Jr., Intrajoint comparisons of gene expression patterns in human osteoarthritis suggest a change in chondrocyte phenotype. J Orthop Res. 2005; 23: 1128-38.
42. Ezura Y, Sekiya I, Koga H, Muneta T, Noda M., Methylation status of CpG islands in the promoter regions of signature genes during chondrogenesis of human synovium-derived mesenchymal stem cells. Arthritis Rheum. 2009; 60: 1416-26.
43. Eissenberg JC, Shilatifard A., Histone H3 lysine 4 (H3K4) methylation in development and differentiation. Dev Biol. 2010; 339: 240-9.
44. Ho L, Crabtree GR., Chromatin remodelling during development. Nature. 2010; 463: 474-84.
45. Li E., Chromatin modification and epigenetic reprogramming in mammalian development. Nat Rev Genet. 2002; 3: 662-73.